SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 01, 17:00
859.90
0
VOLUME 308,222
LIVE
NSE
Apr 01, 17:00
859.80
0
VOLUME 5,415,702
News on Ranbaxy Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

1.20 pm | 22 Apr 2015 |  Source: PTI

The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from...

Weakness in Sun Pharma a buying opportunity: IIFL 

12.46 pm | 22 Apr 2015 |  Source: CNBC-TV18

The pharma space has been in focus post Sun Pharma-Daiichi deal and the likelihood of a possible merger between Teva and Mylan globally. In an intervi...

Daiichi Sankyo to offload stake in Sun Pharma 

8.15 pm | 20 Apr 2015 |  Source: PTI

As part of the deal, Ranbaxy shareholders were to receive 0.8 Sun Pharma shares for every Ranbaxy share they held. Daiichi Sankyo, which had acquired ...

Daiichi Sankyo to sell 8.9% in Sun Pharma at Rs 932-1043/sh 

6.13 pm | 20 Apr 2015 |  Source: CNBC-TV18

Goldman Sachs is learnt to be the banker to Sun Pharma-Daiichi Sankyo deal....

Hold Reliance Industries; target Rs 980: Gaurang Shah 

3.46 pm | 10 Apr 2015 |  Source: CNBC-TV18

Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may hold Reliance Industries with a target Rs 980....

Hold Sun Pharma: Mayuresh Joshi 

4.28 pm | 06 Apr 2015 |  Source: CNBC-TV18

Mayuresh Joshi - fund manager - PMS at Angel Broking recommends holding Sun Pharma....

Sun Pharma up 4%, settles Angiomax litigation with US co

11.19 am | 06 Apr 2015 |  Source: Moneycontrol.com

Investors bought more shares of Sun Pharmaceutical Industries on Monday on settlement of litigation with the US company. The stock rallied more than 4...

Sun Pharma up 5.5%; Morgan Stanley says top pick, ups tgt

5.52 pm | 01 Apr 2015 |  Source: Moneycontrol.com

Investors continued its buying interest in Sun Pharmaceutical Industries on Wednesday after Morgan Stanley retained its overweight rating on the stock...

Check out: Investment ideas by market experts 

4.18 pm | 01 Apr 2015 |  Source: CNBC-TV18

Watch the interview of Mayuresh Joshi of Angel Broking to answer all your stock queries and Kalpesh Ashar of Full Circle Financial Planners & Advisors...

Stay invested in Sun Pharma: Mayuresh Joshi 

4.07 pm | 01 Apr 2015 |  Source: CNBC-TV18

According to Mayuresh Joshi of Angel Broking, one may stay invested in Sun Pharmaceutical Industries....

Stocks in news: Adani Ent, RIL, GVK, eClerx, RCF, Kalpataru

8.24 am | 01 Apr 2015 |  Source: CNBC-TV18

Coal India | Adani Enterprises | Sun Pharma | Mangalore Chemicals | Reliance Industries | Philips India | JSW Steel | GMR Infra | GVK Power | Clariant...

Expect upside in Sun Pharma: Abhishek Sharma 

2.28 pm | 26 Mar 2015 |  Source: CNBC-TV18

Abhishek Sharma, pharma analyst at IIFL is of the view that one may see upside in Sun Pharmaceutical Industries....

Positive on Lupin on strong pipeline for US mkt: IIFL 

12.27 pm | 26 Mar 2015 |  Source: CNBC-TV18

Pharma Analyst, Abhishek Sharma of IIFL spoke with Ekta Batra & Anuj Singhal of CNBC-TV18. He shared his reading and outlook on the pharmaceutical spa...

No plan to merge SPARC with Sun Pharma: Dilip Shanghvi 

7.18 pm | 25 Mar 2015 |  Source: CNBC-TV18

With Sun Pharma-Ranbaxy merger complete, Sun is now India's largest and the world's fifth largest drug maker with combined revenue of USD 5.14 billion...

Focus will be to regain regulators' confidence: Sun Pharma

5.43 pm | 25 Mar 2015 |  Source: Moneycontrol.com

Shanghvi, who replaced Mukhesh Ambani as India’s richest man on March 4, said the company's "most important focus" would be to regain the confidence...

Invest in Sun Pharma, says Mayuresh Joshi 

3.31 pm | 25 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that one may invest in Sun Pharmaceutical Industries....

Sun Pharma to delist Ranbaxy on completion of $ 4 bn merger

2.35 pm | 25 Mar 2015 |  Source: PTI

The merger has fortified Sun Pharma's position as the world's fifth largest speciality generic pharmaceutical firm and the top ranking Indian pharma c...

Sun Pharma open to large acquisitions post Ranbaxy deal

2.26 pm | 25 Mar 2015 |  Source: Reuters

The company will look to invest more than USD 300 million in research and development and is not considering any job cuts post the close of the deal, ...

See 10% overall growth for Sun-Ranbaxy entity: Surajit Pal  

2.21 pm | 25 Mar 2015 |  Source: CNBC-TV18

or the investors who are holding the stock should continue to hold it but fresh entry should be made only if it corrects from the current levels, says...

Eyeing over $300mn R&D spend; Ranbaxy to delist: Sun Pharma 

1.22 pm | 25 Mar 2015 |  Source: Moneycontrol.com

The merger has fortified Sun Pharma’s position as the world’s fifth-largest specialty generic pharmaceutical company and the top Indian Pharma com...

1 2 3 4 5
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.